Literature DB >> 16325618

Fecal incontinence in US women: a population-based study.

Jennifer L Melville1, Ming-Yu Fan, Katherine Newton, Dee Fenner.   

Abstract

OBJECTIVE: The purpose of this study was to determine the prevalence of fecal incontinence (FI) and associated risk factors in a broad age range of community-dwelling women. STUDY
DESIGN: This was a population-based, age-stratified postal survey of 6000 women aged 30 to 90 years enrolled in a large HMO in Washington State. Sample was linked to longitudinal automated medical data. FI was defined as loss of liquid or solid stool at least monthly.
RESULTS: The response rate was 64%. The prevalence of FI was 7.2%; prevalence increased notably with age. Women with FI reported significant lifestyle alteration and functional disability. Older age (adjusted odds ratio [OR] 2.11-2.22), major depression (OR 2.73), urinary incontinence (OR 2.32), medical comorbidity (OR 1.76-2.58), and operative vaginal delivery (OR 1.52) were significantly associated with increased odds of FI.
CONCLUSION: In this large report of US community-dwelling women, FI was a prevalent condition. Age, major depression, urinary incontinence, medical illness, and operative vaginal delivery were strongly associated with likelihood of FI.

Entities:  

Mesh:

Year:  2005        PMID: 16325618     DOI: 10.1016/j.ajog.2005.07.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  69 in total

1.  Fecal incontinence in older women: are levator ani defects a factor?

Authors:  Christina Lewicky-Gaupp; Cynthia Brincat; Aisha Yousuf; Divya A Patel; John O L Delancey; Dee E Fenner
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study.

Authors:  Alayne D Markland; Patricia S Goode; Kathryn L Burgio; David T Redden; Holly E Richter; Patricia Sawyer; Richard M Allman
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

3.  Office-based management of fecal incontinence.

Authors:  Vanessa C Costilla; Amy E Foxx-Orenstein; Anita P Mayer; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-07

Review 4.  Impact of fecal incontinence and its treatment on quality of life in women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2015-03

5.  The anatomy of Trans-Obturator Posterior Anal Sling (TOPAS) and dynamics of potential mechanism of action.

Authors:  J Alshiek; P Rosenblatt; S A Shobeiri
Journal:  Tech Coloproctol       Date:  2019-08-03       Impact factor: 3.781

6.  Perianal implantation of bioengineered human internal anal sphincter constructs intrinsically innervated with human neural progenitor cells.

Authors:  Shreya Raghavan; Eiichi A Miyasaka; Robert R Gilmont; Sita Somara; Daniel H Teitelbaum; Khalil N Bitar
Journal:  Surgery       Date:  2013-12-27       Impact factor: 3.982

7.  Obstetric sphincter injury interacts with diarrhea and urgency to increase the risk of fecal incontinence in women with irritable bowel syndrome.

Authors:  Barbara L Robinson; Catherine A Matthews; Olafur S Palsson; Elizabeth Geller; Marsha Turner; Brent Parnell; Andrea Crane; Mary Jannelli; Ellen Wells; Annamarie Connolly; Feng-Chang Lin; William E Whitehead
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Jan-Feb       Impact factor: 2.091

8.  Risk factors for fecal incontinence in older women.

Authors:  Mary K Townsend; Catherine A Matthews; William E Whitehead; Francine Grodstein
Journal:  Am J Gastroenterol       Date:  2012-10-23       Impact factor: 10.864

9.  The bother of anal incontinence and St. Mark's Incontinence Score.

Authors:  C Paka; I K Atan; H P Dietz
Journal:  Tech Coloproctol       Date:  2015-11-16       Impact factor: 3.781

10.  Racial differences in fecal incontinence in community-dwelling women from the EPI study.

Authors:  Mitchell B Berger; John O Delancey; Dee E Fenner
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 May-Jun       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.